- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
MIS plans to produce radiopharmaceuticals in U.K.
Molecular Imaging Services has signed an agreement to establish a commercial radiopharmaceutical production unit at Keele University Science Park in Staffordshire, U.K. The unit will produce PET radiopharmaceuticals. MIS was established in 2002 as a
Molecular Imaging Services has signed an agreement to establish a commercial radiopharmaceutical production unit at Keele University Science Park in Staffordshire, U.K. The unit will produce PET radiopharmaceuticals. MIS was established in 2002 as a joint venture between Phoenix-based Alliance Medical and Dublin-based M2i. Its primary goal is to establish a number of such production units to support the expanded use of PET in the U.K.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
